Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Current Assets (2016 - 2025)

PAVmed has reported Current Assets over the past 6 years, most recently at $2.6 million for Q4 2025.

  • For Q4 2025, Current Assets rose 18.16% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, up 18.16%, while the annual FY2025 figure was $2.6 million, 18.16% up from the prior year.
  • Current Assets for Q4 2025 was $2.6 million at PAVmed, down from $4.2 million in the prior quarter.
  • Over five years, Current Assets peaked at $82.6 million in Q4 2021 and troughed at $2.2 million in Q4 2024.
  • A 5-year average of $36.0 million and a median of $37.1 million in 2021 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: surged 336.29% in 2021 and later plummeted 91.17% in 2024.
  • Year by year, Current Assets stood at $82.6 million in 2021, then tumbled by 46.84% to $43.9 million in 2022, then tumbled by 44.23% to $24.5 million in 2023, then plummeted by 91.17% to $2.2 million in 2024, then rose by 18.16% to $2.6 million in 2025.
  • Business Quant data shows Current Assets for PAVM at $2.6 million in Q4 2025, $4.2 million in Q3 2025, and $5.5 million in Q2 2025.